Highly-qualified Laboratory Manager with top-notch planning and problem-solving abilities. Open and clear communicator with disciplined and thorough approach.
Research
1. Chaudhary P., Das-Earl P, and Schreihofer AM. Preserved glycemic control and baroreflex efficacy in young adult hypertensive female obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 2021 May 12. . doi: 10.1152/ajpregu.00341.2020.
2. Earl DE, Das P, Gunning III WT, and Tietz EI. . Regulation of Ca2+/calmodulin-dependent protein kinase II signaling within hippocampal glutamatergic postsynapses during flurazepam withdrawal. Maladaptive Plasticity in Neurological Diseases. Special Issue of Neural Plasticity, 2012:405926. doi: 10.1155/2012/405926. Epub 2012
3. Das P., Zerda R., Alvarez F.J. and Tietz E.I. Immunogold electron microscopic evidence of differential regulation of GluN1, GluN2A and GluN2B, NMDA-type glutamate receptor subunits in rat hippocampal synapses during benzodiazepine withdrawal. J. Comp. Neurol., 518(21):4311-4328, 2010
4. Lu S., Das P., Fadool D.A., and Kaczmarek L.K. The slack sodium-activated potassium channel provides a major outward current in olfactory neurons of Kv1.3-/- super-smeller mice. J. Neurophysiol., 103: 3311-3319, 2010.
5. Shen G., Mohammed M.S., Das P., and Tietz E.I. Positive allosteric activation of GABAA receptors bi-directionally modulates hippocampal glutamate plasticity and behaviour. Biochem Soc Trans 37 (Pt 6):1394-1398, 2009.
6. Das P., Lilly S.M., Zerda R, Gunning III W.T., Alvarez F.J. and Tietz E.I. Increased AMPA receptor GluR1 subunit incorporation in rat hippocampal CA1 synapses during benzodiazepine withdrawal. J. Comp. Neurol., 511, 832-846, 2008.
7. Das P., Parson A.D., Scarborough J., Hoffman J., Wilson J., Thompson R.N., Overton J.M., and Fadool D.A. Electrophysiological and behavioral phenotype of insulin receptor defective mice. Physiology and Behavior, 86, 287-296, 2005.
8. Das P., and Dillon G.H. Molecular determinants of picrotoxin inhibition of 5-Hydroxytryptamine type 3 receptor. J. Pharmacol. And Exp Thera. 314 (1), 320-328, 2005.
9. Das P., Bell-Horner C.L., Huang R.Q., Raut A., Gonzales E.B., Covey D.F., and Dillon G.H. Inhibition of recombinant GABAA receptors by L-type calcium channel blockers. Neurosci., 124(1), 195-206, 2004.
10. Das P., and Dillon G.H. The 5-HT3B subunit reduces picrotoxin sensitivity when co- expressed with the 5-HT3A receptor. Mol. Brain. Res., 119 (2), 207-212, 2003.
11. Das P., Bell-Horner C.L., Machu T.K., and Dillon G.H. The GABAA receptor antagonist picrotoxin inhibits 5-Hydroxytryptamine type 3A receptors. Neuropharmacol., 44, 431-438, 2003.